CTLA4 and neoplasm: In a murine melanoma vaccine model, inhibition of both CTLA-4 or PD-1 increased the proportion of CTLA-4 and PD-1-expressing CD4/CD8 tumor infiltrating T effector cells and decreased intratumoral T regulatory cells, as compared to either agent alone [65].